Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other neoplasm 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Myelodysplastic Syndromes 355Leukemia, Myeloid, Acute 297Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 101Leukemia, Myelomonocytic, Chronic 88Lymphoma, Non-Hodgkin 76Leukemia 69Polycythemia Vera 61Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 48Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma 40Leukemia, Biphenotypic, Acute 40Thrombocythemia, Essential 39Myelodysplastic-Myeloproliferative Diseases 31Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 22Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Processes × Myeloid × 1 year × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡